Testing lab ways to measure a tracer that sticks to IDH1
Original title: Methods for assessing binding of a small-molecule radioligand to soluble enzyme isocitrate dehydrogenase 1 variants.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was lab work with enzymes only, not in people.
The short version
Scientists checked lab methods for a tracer that might one day show IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary tumors on a scan.
What was studied. Researchers worked with the IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary enzyme in the lab. They tested a radioactive form of the drug ivosidenib and used several lab methods to see how well it stuck.
What they found. The tracer stuck to the normal IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary enzyme and to the changed form, called IDH1R132H. It stuck even when only tiny amounts of tracer were used. But each lab method gave a different answer for how tightly it stuck.
What this means, and what it doesn't
What it could mean: Some gliomas have a change in the IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary gene. A scan tracer could someday show that change without surgery. This work helps set up the lab tests needed to build one.
What it doesn't mean: This is not a treatment, and it is not a cure. It is very early lab work with enzymes in a dish. No person was scanned or treated in this study. The authors also say the lab methods need more work before the numbers can be trusted. Any real scan for patients would be many years away, if it happens at all.
Source: PubMed, September 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.